Ladenburg Thalmann Financial Services’s Aegerion Pharmaceuticals AEGR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$1K	–	5089
2016 Q3	$1K	Sell	300 -11	-4%	-$19	﹤0.01%	4738
2016 Q2	$0	Hold	311	–	–	﹤0.01%	4962
2016 Q1	$1K	Sell	311 -339	-52%	-$2.1K	﹤0.01%	4633
2015 Q4	$7K	Hold	650	–	–	﹤0.01%	3928
2015 Q3	$9K	Buy	650 +300	+86%	+$5.34K	﹤0.01%	3636
2015 Q2	$7K	Hold	350	–	–	﹤0.01%	3932
2015 Q1	$9K	Hold	350	–	–	﹤0.01%	3732
2014 Q4	$7K	Sell	350 -300	-46%	-$7.56K	﹤0.01%	3614
2014 Q3	$22K	Sell	650 -600	-48%	-$18.6K	﹤0.01%	2614
2014 Q2	$40K	Buy	1,250 +200	+19%	+$7.45K	﹤0.01%	2194
2014 Q1	$48K	Buy	1,050 +600	+133%	+$35.2K	﹤0.01%	2011
2013 Q4	$32K	Buy	450 +442	+5,525%	+$33.8K	﹤0.01%	2235
2013 Q3	$1K	Buy	+8	New	+$678	﹤0.01%	3632

Ladenburg Thalmann Financial Services's AEGR Position: Q4 2016 in Review

Ladenburg Thalmann Financial Services sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 300 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in AEGR in Q3 2013 and held it in 13 quarters. The position peaked at $48K in Q1 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Ladenburg Thalmann Financial Services reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 300 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 13 quarters.
Ladenburg Thalmann Financial Services's Aegerion Pharmaceuticals position peaked at $48K in Q1 2014.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2016, filed 14 Feb 2017.